ArticleBreast cancer research and treatment2025
Higher pre-diagnostic serum syndecan-4 levels are associated with increased breast cancer risk: a case-cohort study.
Endre Gabrielsen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.